Praram 9 Hospital PCL (BKK:PR9)

Market Cap	12.74B -34.7%
Revenue (ttm)	5.39B +10.9%
Net Income	806.77M +7.0%
EPS	1.03 +7.0%
Shares Out	786.30M
PE Ratio	15.79
Forward PE	14.62
Dividend	0.50 (3.07%)
Ex-Dividend Date	Apr 30, 2026

Volume	1,967,608
Open	16.40
Previous Close	16.30
Day's Range	16.20 - 16.50
52-Week Range	15.70 - 26.75
Beta	0.13
Analysts	Strong Buy
Price Target	22.92 (+41.48%)
Earnings Date	Aug 7, 2026

About Praram 9 Hospital PCL

Praram 9 Hospital Public Company Limited engages in hospital operations primarily in Thailand. The company operates medicine, surgery, diabetes and metabolic, spine, orthopedic, physical therapy and rehabilitation, chest and respiratory, neurology, thyroid and thyroid surgery, obstetrics gynecology, IVF, breast, oncocare, emergency, imaging, Lasik, skin and plastic surgery, mind, gastrointestinal and liver disease, dental, check-up, eye, pediatric, sleep, ear, nose, and throat centers, as well as vaccination and travel medicine, and traditional...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 1992
• Employees: 1,750
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: PR9

Financial Performance

In 2025, Praram 9 Hospital PCL's revenue was 5.34 billion, an increase of 13.88% compared to the previous year's 4.69 billion. Earnings were 822.71 million, an increase of 15.44%.

Analyst Summary

According to 13 analysts, the average rating for PR9 stock is "Strong Buy." The 12-month stock price target is ฿22.92, which is an increase of 41.48% from the latest price.

Price Target

฿22.92

(41.48% upside)

Analyst Consensus: Strong Buy